Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Statistics

Total Valuation

NEUP has a market cap or net worth of $22.10 million. The enterprise value is $8.57 million.

Market Cap	22.10M
Enterprise Value	8.57M

Important Dates

The next estimated earnings date is Friday, February 13, 2026, before market open.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

NEUP has 5.38 million shares outstanding. The number of shares has decreased by -99.94% in one year.

Current Share Class	5.38M
Shares Outstanding	5.38M
Shares Change (YoY)	-99.94%
Shares Change (QoQ)	+18.13%
Owned by Insiders (%)	3.42%
Owned by Institutions (%)	26.83%
Float	4.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.49
Forward PS	n/a
PB Ratio	0.77
P/TBV Ratio	n/a
P/FCF Ratio	30.88
P/OCF Ratio	30.88
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	11.97

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.01.

Current Ratio	2.72
Quick Ratio	2.66
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	0.17
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.04% and return on invested capital (ROIC) is -12.18%.

Return on Equity (ROE)	-64.04%
Return on Assets (ROA)	-7.25%
Return on Invested Capital (ROIC)	-12.18%
Return on Capital Employed (ROCE)	-13.12%
Revenue Per Employee	$1.96M
Profits Per Employee	-$1.18M
Employee Count	8
Asset Turnover	0.62
Inventory Turnover	n/a

Taxes

Income Tax	-370,972
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.86%
50-Day Moving Average	4.21
200-Day Moving Average	7.24
Relative Strength Index (RSI)	47.72
Average Volume (20 Days)	55,187

Short Selling Information

The latest short interest is 24,781, so 0.46% of the outstanding shares have been sold short.

Short Interest	24,781
Short Previous Month	21,719
Short % of Shares Out	0.46%
Short % of Float	0.60%
Short Ratio (days to cover)	0.31

Income Statement

In the last 12 months, NEUP had revenue of $15.65 million and -$9.47 million in losses. Loss per share was -$5.09.

Revenue	15.65M
Gross Profit	15.65M
Operating Income	-2.91M
Pretax Income	-9.84M
Net Income	-9.47M
EBITDA	-2.25M
EBIT	-2.91M
Loss Per Share	-$5.09

Balance Sheet

The company has $13.65 million in cash and $118,220 in debt, with a net cash position of $13.53 million or $2.52 per share.

Cash & Cash Equivalents	13.65M
Total Debt	118,220
Net Cash	13.53M
Net Cash Per Share	$2.52
Equity (Book Value)	12.51M
Book Value Per Share	5.31
Working Capital	8.83M

Cash Flow

Operating Cash Flow	715,644
Capital Expenditures	n/a
Free Cash Flow	715,644
FCF Per Share	$0.13

Margins

Gross margin is 100.00%, with operating and profit margins of -18.62% and -60.52%.

Gross Margin	100.00%
Operating Margin	-18.62%
Pretax Margin	-62.89%
Profit Margin	-60.52%
EBITDA Margin	-14.39%
EBIT Margin	-18.62%
FCF Margin	4.57%

Dividends & Yields

NEUP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	99.94%
Shareholder Yield	99.94%
Earnings Yield	-42.86%
FCF Yield	3.24%

Analyst Forecast

The average price target for NEUP is $21.00, which is 408.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	408.48%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	31.95%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NEUP has an Altman Z-Score of -8.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.54
Piotroski F-Score	2